Yp. Liu et al., OLEANOLIC ACID PROTECTS AGAINST CADMIUM HEPATOTOXICITY BY INDUCING METALLOTHIONEIN, The Journal of pharmacology and experimental therapeutics, 266(1), 1993, pp. 400-406
Oleanolic acid (OA) is a triterpenoid compound that has been shown to
protect against some hepatotoxicants and is used in China to treat hep
atitis. This study was conducted to examine the protective effects of
OA against cadmium (Cd)-induced liver injury in mice and the mechanism
of protection. OA (100 mg/kg x 3 days) pretreatment dramatically decr
eased Cd (3.7 mg/kg i.v.)-induced liver injury as indicated by decreas
ed serum activities of alanine aminotransferase and sorbitol dehydroge
nase, as well as by histopathological observation. To examine the mech
anism of protection, the distribution of Cd to major organs and the he
patic subcellular distribution of Cd were determined 2 hr after Cd-109
injection (3.5 mg/kg of Cd and 10 muCi/mg of Cd i.v.). OA did not red
uce the amount of Cd in liver, but significantly altered the hepatic s
ubcellular distribution of Cd, with more Cd in hepatic cytosol bound t
o metallothionein (MT), and with less Cd in other organelles and prote
ins. OA produced an approximately 30-fold increase in hepatic MT, but
had no appreciable effects on MT levels of five other organs. Furtherm
ore, OA increased both hepatic MT-I and MT-II levels, as determined by
high-performance liquid chromatography/atomic absorption spectrophoto
metry. Northern blot analysis revealed that OA increases MT mRNA expre
ssion. In summary, OA pretreatment protects against Cd-induced hepatot
oxicity by inducing MT. MT bound Cd in the cytosol, and thus decreased
the amount of Cd in other critical organelles and proteins. OA is a h
epatic MT inducer for both MT-I and MT-II isoforms, and this effect is
due, at least in part, to an increased MT mRNA accumulation.